Sunday - July 26, 2026
Goodwin Guides IP for Pharmakon on Up to $200 Million Financing for Kestra Medical Technologies
July 20, 2026
BOSTON, Massachusetts, July 20 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Guides IP for Pharmakon on Up to $200 Million Financing for Kestra Medical Technologies

*

The Life Sciences team advised Pharmakon Advisors, LP, on the intellectual property aspects of its five-year term loan facility providing Kestra Medical Technologies, Ltd., (Nasdaq: KMTS) with up to $200 million in non-dilutive f . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products